Presentation Resources
-Addiction. 2009 Jan;104(1):13-24. doi: 10.1111/j.1360- 0443.2008.02364.x. Epub 2008 Oct
Summary only:
-Cochrane Database Syst Rev. 2006 Jul 19;(3):CD005194.
Summary only:
Related Resources
Breggin, P. R., (2013). Psychiatric Drug Withdrawal: A Guide for Prescribers, Therapists,
Patients and Their Families. Springer.
Pollmann AS, Murphy AL, Bergman JC, Gardner DM. Deprescribing benzodiazepines and
Z-drugs in community-dwelling adults: a scoping review. BMC Pharmacol Toxicol.
2015;16:19. Published 2015 Jul 4. doi:10.1186/s40360-015-0019-8
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4491204/
U.S. Department of Veterans’ Affairs. (2016). Re-evaluating the Use of Benzodiazepines: A
Quick Reference Guide. Washington DC: www.va.gov
https://www.pbm.va.gov/PBM/AcademicDetailingService/Documents/Academic_Detailing_Educational_Material_Catalog/23_Benzodiazepine_Provider_AD_Quick_Reference_Guide_IB10_929.pdf
Stahl, S. Anxiety disorders and anxiolytics. Stahl’s Essential PsychopharmacologyNeuroscientific Basis and Practice Application. 2018.
Smith, R. V., Havens, J. R., and Walsh, S. L. (2016) Gabapentin misuse, abuse and
diversion: a systematic review. Addiction, 111: 1160– 1174. doi: 10.1111/add.13324.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5573873/
Trevor, A. (2018). Sedative-Hypnotic Drugs. Basic and Clinical Pharmacology, 15th ed. New
Yourk NY: McGraw-Hill.